Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis consumer health s.a, switzerland - oral solution - 15 ml - sodium chloride solution

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide yellow - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - dimetindene maleate - gel - dimetindene maleate 0.1 %w/w - dimetindene - dimetindene - urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline consumer healthcare sdn. bhd. - terbinafine hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis consumer health australasia pty ltd (nz) - diclofenac potassium 25mg;  ;   - tablet - 25 mg - active: diclofenac potassium 25mg     excipient: calcium phosphate colloidal silicon dioxide iron oxide red macrogol 8000 magnesium stearate maize starch microcrystalline cellulose opacode brown s-1-9210hv povidone   purified talc sodium starch glycolate sucrose titanium dioxide

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis consumer health uk ltd - nicotine - medicated chewing-gum - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis consumer health uk ltd - nicotine - medicated chewing-gum - 4mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis consumer health uk ltd - cetrimide; chlorhexidine gluconate - cutaneous liquid - 30mg/1ml ; 3mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 320 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; crospovidone; microcrystalline cellulose; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); hydrochlorothiazide, quantity: 25 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; crospovidone; microcrystalline cellulose; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).